Health
Explainer
The 2026 Dietary Guidelines Flip the Food Pyramid: Why Protein and Fat Now Form the Base
6 sources · 59d ago
Explainer
Landmark Research: Single Dose of Amphibian-Derived Bacterium Eliminates Colorectal Tumors in Mice
3 sources · 59d ago
Bone Health
Massive Review of 154,000 People Finds Calcium and Vitamin D Supplements Offer Little Benefit Against Fractures
2 sources · 60d ago
More in Health
ExplainerPsychedelic Medicine
The Evidence Pack: Why the FDA Declined MDMA-Assisted Therapy for PTSD
Regulatory & Methodological Skeptics 40%Psychedelic Researchers & Advocates 30%Patient Advocates & Veterans 30%
5 sources · 60d ago
ExplainerCancer Prevention
The Evidence Pack: How Nutritional Science Can Intercept the WHO's 2050 Cancer Projections
Public Health Systemicists 40%Metabolic Oncology Researchers 40%Global Equity Advocates 20%
7 sources · 60d ago
Research BriefNeuroendocrinology
FDA Approves First Therapy for Acquired Hypothalamic Obesity Following Landmark Phase 3 Trial
Endocrinology Researchers 40%Patient Advocacy Groups 35%Healthcare Regulators 25%
3 sources · 60d ago
Addiction MedicineEvidence Pack
FDA Fast-Tracks First Ibogaine Derivative Trial for Alcohol Use Disorder
Psychedelic Medicine Advocates 40%Public Health & Policy Officials 35%Clinical Safety Skeptics 25%
3 sources · 61d ago
ExplainerPsychedelic Medicine
Landmark Phase 3 Trial Finds Single-Dose Psilocybin Provides Six-Month Relief for Severe Depression
Clinical Researchers 44%Healthcare Administrators 33%Patient Advocates 22%
6 sources · 61d ago
ExplainerFood Fortification
Landmark Study: Global Food Fortification Prevents 7 Billion Nutrient Gaps Annually, Could Triple Impact
Public Health Experts 50%Food Industry & Millers 30%Dietary Diversity Advocates 20%
6 sources · 61d ago
Precision OncologyExplainer
Landmark Trial: Eli Lilly Drug Slashes Early-Stage Lung Cancer Recurrence Risk by 83%
Clinical Oncologists 45%Patient Advocates 35%Pharmaceutical Industry 20%
3 sources · 61d ago
Research BriefMetabolic Disease
Landmark Phase 3 Trial: New Oral GLP-1 Pill Orforglipron Outperforms Semaglutide for Weight Loss and Diabetes Control
Metabolic Disease Specialists 40%Pharmaceutical Analysts 35%Clinical Cautious Voices 25%
4 sources · 61d ago
Menopause CareExplainer
Landmark 20-Year WHI Follow-up Reverses Hormone Therapy Fears for Younger Menopausal Women
Medical Consensus 50%Patient Advocates 30%Cautious Oncologists 20%
4 sources · 56d ago
ExplainerPain Management
FDA Approves First-in-Class Oral Non-Opioid Drug for Acute Pain, Offering Alternative to Addictive Narcotics
Pain Medicine Specialists 35%Addiction Recovery Advocates 35%Biomedical Researchers 30%
8 sources · 62d ago
ExplainerIgA Nephropathy
The Evidence Pack: How a First-in-Class Dual Inhibitor is Rewriting the Treatment of IgA Nephropathy
Nephrology Researchers 40%Patient Advocacy Groups 35%Regulatory & Safety Watchdogs 25%
6 sources · 62d ago
ExplainerACA Subsidies
What the Expiration of Enhanced ACA Subsidies Means for Health Coverage in 2026
Health Policy Researchers 40%Federal Administrators 35%Healthcare Providers 25%
3 sources · 62d ago
ExplainerMetabolic Psychiatry
Landmark Research Suggests Mental Illness Starts in Brain Cells, Shifting Focus From Neurotransmitters to Cellular Metabolism
Metabolic Psychiatry Pioneers 45%Traditional Neurobiologists 35%Clinical Innovators 20%
4 sources · 62d ago
Research BriefADHD Innovation
First-in-Class NDSRI Centanafadine Poised to Reshape ADHD Treatment for All Ages
Clinical Psychiatrists 40%Neuropharmacology Researchers 30%Patient Advocates 30%
6 sources · 63d ago
ExplainerWomen's Health
How a New Androgen 'Fingerprint' is Making Non-Surgical Endometriosis Diagnosis a Reality
Clinical Researchers 40%Patient Advocates 35%Public Health Officials 25%
5 sources · 63d ago
ExplainerPsychedelic Therapy
The Evidence Pack: How the White House Mandate is Accelerating Psychedelic Medicine
Clinical Researchers & Drug Sponsors 40%Veteran & Patient Advocates 35%Regulatory Skeptics 25%
6 sources · 63d ago
Blindspot
Important stories the mainstream barely covered
High-impact news with only 1–3 outlets covering it. These stories matter — they just didn't make the radar.